Methocarbamol and Flexeril are not the same medication. They are two different drugs that both belong to the skeletal muscle relaxant class, but they contain different active ingredients, work differently in the body, and have distinct side effect profiles. Flexeril is the brand name for cyclobenzaprine, while methocarbamol is sold under the brand name Robaxin.
Because both are commonly prescribed for muscle spasms and pain, they’re easy to confuse. But the differences between them matter, especially when it comes to drowsiness, how long you take them, and who should avoid them.
What Each Drug Is Used For
Both methocarbamol and cyclobenzaprine (Flexeril) are prescribed for acute musculoskeletal pain, the kind that comes from strains, sprains, or muscle injuries. They’re typically used alongside rest and physical therapy rather than as standalone treatments. Cyclobenzaprine is one of the most well-studied muscle relaxants and is generally prescribed for short-term use of two to three weeks. Methocarbamol is typically considered when other treatments for musculoskeletal pain haven’t worked.
Neither drug is designed for long-term use or for spasticity caused by neurological conditions like cerebral palsy or multiple sclerosis. Those conditions require a different category of muscle relaxant entirely.
How They Work Differently
Although both drugs reduce muscle spasms, they act through different pathways in the central nervous system. Cyclobenzaprine is structurally similar to older antidepressant medications, which is why it tends to produce more pronounced effects like dry mouth and drowsiness. It works primarily in the brain to reduce muscle hyperactivity. Methocarbamol also acts centrally, but through a different mechanism that generally produces fewer of those antidepressant-like side effects.
This distinction in how they work explains many of the practical differences people notice when taking one versus the other.
Side Effects Compared
Drowsiness is the most commonly reported side effect for both drugs, but it’s significantly more common with Flexeril. About 20% of cyclobenzaprine users report drowsiness compared to roughly 9% of methocarbamol users. Cyclobenzaprine also causes dry mouth in nearly 1 in 10 users, along with tiredness (5.3%) and depression (4.1%). A small percentage of users (2.5%) have reported hallucinations.
Methocarbamol’s side effect profile looks different. Insomnia shows up in about 7% of users, which is notable since you might expect a muscle relaxant to cause the opposite problem. Headaches and nausea each affect about 4% of users, and dizziness occurs at a similar rate.
The two drugs also interact differently with pre-existing health conditions. Cyclobenzaprine can be problematic for people with cardiovascular disease and tends to produce stronger anticholinergic effects, meaning it can cause dry mouth, constipation, blurred vision, and urinary retention. Methocarbamol raises more concern for people with kidney problems or a history of seizures.
How Effective Are They?
A study comparing seven muscle relaxants head-to-head in emergency department patients with acute low back pain found no statistically significant difference between any of them, or between any of them and placebo. All patients in the study also took an anti-inflammatory drug. The improvement scores were similar across the board: cyclobenzaprine users improved by about 10 points on a standard disability questionnaire, while methocarbamol users improved by about 8 points. Placebo landed at 10.5 points. None of these differences were statistically meaningful.
This doesn’t mean the drugs do nothing for individual patients. Some people respond well to one and not the other. But the research suggests that when used on top of an anti-inflammatory, adding a muscle relaxant may not provide much extra benefit for acute low back pain specifically.
Dosing Differences
Cyclobenzaprine comes in both standard tablets and extended-release capsules. The typical tablet dose is 10 mg taken three times a day, with a maximum of 60 mg daily. The extended-release version is taken once a day, usually at 15 mg, with some patients going up to 30 mg. Methocarbamol is dosed differently and typically at higher milligram amounts per tablet, though the total daily dose varies based on severity.
Both medications are meant for short-term use. Cyclobenzaprine prescriptions usually cap at two to three weeks.
Safety for Older Adults
Both methocarbamol and cyclobenzaprine appear on the American Geriatrics Society’s Beers Criteria, a list of medications considered potentially harmful for adults over 65. This list also includes other muscle relaxants like carisoprodol, metaxalone, chlorzoxazone, and orphenadrine. The concern for older adults centers on the increased risk of sedation, falls, and cognitive side effects that come with this entire drug class.
Mixing With Alcohol and Other Drugs
Both medications depress the central nervous system, slowing brain activity, breathing rate, and heart rate. Alcohol does the same thing. Combining either muscle relaxant with alcohol can intensify side effects well beyond what you’d experience from either one alone, leading to dangerous levels of drowsiness, slowed breathing, reduced coordination, memory problems, and increased seizure risk.
The same compounding effect applies when either drug is taken with opioid painkillers, benzodiazepines like alprazolam, tricyclic antidepressants, or certain other medications. This is especially relevant for cyclobenzaprine given its structural similarity to tricyclic antidepressants.
Neither Is a Controlled Substance
Unlike some other muscle relaxants (carisoprodol, for instance, is a Schedule IV controlled substance), neither methocarbamol nor cyclobenzaprine is classified as a controlled substance by the DEA. That said, both can still cause dependence with prolonged use and should not be stopped abruptly after extended periods without medical guidance.
Which One Gets Prescribed
The choice between methocarbamol and cyclobenzaprine often comes down to side effect tolerance. If drowsiness is a concern, methocarbamol may be the better option since it causes less sedation. If dry mouth, constipation, or heart rhythm issues are relevant factors, cyclobenzaprine’s stronger anticholinergic properties make it less ideal. For people with kidney problems, methocarbamol requires more caution.
Both drugs were among the top 200 most dispensed medications in the U.S. as of 2006, and they remain widely prescribed. They’re similar enough in purpose that people often assume they’re interchangeable, but the differences in side effects and drug interactions make the distinction worth understanding.